223
Participants
Start Date
January 31, 2005
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2011
Placebo
placebo infusion, single
EZ-2053
single IV infusion, 9 mg/kg
EZ-2053 5mg/kg
single IV infusion, 5mg/kg
University of Pennsylvania Medical Center, Philadelphia
Temple University Hospital, Philadelphia
Emory University School of Medicine, Atlanta
Mayo Clinic, Jacksonville
Vanderbilt University, Nashville
University of Kentucky Medical Center, Lexington
Cleveland Clinic, Cleveland
University of Iowa Hospital & Clinics, Iowa City
Barnes-Jewish Hospital, St Louis
INTEGRIS Baptist Medical Center, Oklahoma City
Baylor College of Medicine, Houston
University of Texas Health Sciences Center, San Antonio
Cedars-Sinai Medical Center, Los Angeles
University of California, San Francisco, San Francisco
Stanford University, Stanford
The Alfred Hospital, Melbourne
Medical University of Vienna, Vienna
University of Alberta, Edmonton, Alberta
Toronto General Hospital, Toronto
Lead Sponsor
Neovii Biotech
INDUSTRY